Patents Assigned to MAM Holdings of West Florida, L.L.C.
-
Patent number: 11633432Abstract: A human amniotic fluid formulation has been developed for topical application to the eye, which is useful for the treatment of ocular diseases and injuries including dry eyes, Sjogren's Syndrome, cataracts, burns and injuries to the eye tissues. The formulation is a sterile de-cellularized human amniotic fluid (D-HAF), devoid of amniotic stem cells and elements of micronized membrane or chorion particles. Methods for treating, or preventing various ocular diseases, injuries and disorders using the formulation, optionally in combination with one or more therapeutic, prophylactic or diagnostic agents are described.Type: GrantFiled: June 29, 2018Date of Patent: April 25, 2023Assignee: MAM HOLDINGS OF WEST FLORIDA, L.L.C.Inventor: Carl Randall Harrell
-
Patent number: 11628237Abstract: Compositions containing purified collagen biomaterial derived from tissues, for example, insoluble amnion, soluble amnion, soluble chorion of the human placenta, are provided. The collagen compositions can be used to promote wound healing, promote tissue regeneration, prevent or reduce scarring, reduce local inflammation, minimize tissue rejection, promote graft integration. Methods for using the collagen composition as a biomaterial implant for dermal filling, skin grafting, and hair transplantation are also provided.Type: GrantFiled: July 12, 2018Date of Patent: April 18, 2023Assignee: MAM Holdings of West Florida, L.L.C.Inventor: Carl Randall Harrell
-
Patent number: 11571187Abstract: Provided herein is a pre-Caesarean method for collecting amniotic fluid from a patient. A needle is inserted into the incision site for the future C-section, which may be under ultrasound guidance, through which the amniotic fluid is drawn under a low level suction and, optionally, gravity to a sterile collection container. The method encompasses filtering and/or irradiating the amniotic fluid to collect biomolecules of interest such as growth factors and/or stem cells. Also provided is the sterile amniotic fluid or filtrates thereof collected by the method described herein.Type: GrantFiled: November 14, 2019Date of Patent: February 7, 2023Assignee: MAM HOLDINGS OF WEST FLORIDA, L.L.C.Inventor: Carl Randall Harrell
-
Patent number: 11491189Abstract: Formulations of human amniotic fluid and methods of use thereof for treatment of lung disorders, and/or injuries have been developed. The formulations are suitable for topical delivery to the lung for treatment of lung disorders including chronic obstructive pulmonary disorders (COPD), asthma, emphysema, bronchiectasis, chronic bronchitis, interstitial lung disease, alpha-1 antitrypsin emphysema, as well as for treatment of acute lung injuries. Methods including administering specifically formulated, diluted sterile de-cellularized human amniotic fluids topically to the lungs, preferably as aerosol droplets, are described. In particular, the methods involving administration of the amniotic fluid formulation in the form of aerosol droplets with size between about 1.5 ?m to about 5 ?m, preferably from about 2.5 ?m to about 3.5 ?m, inclusive, using apparatus such as high-efficiency vibrating mesh nebulizers, are described.Type: GrantFiled: January 22, 2018Date of Patent: November 8, 2022Assignee: MAM Holdings of West Florida, L.L.C.Inventor: Carl Randall Harrell
-
Patent number: 10576037Abstract: Provided herein is a topical wound dressing that comprises a collagen and a flexible paste. Also provided is a wound dressing with a first layer of a sterilized mixture of collagen and a second adhesive layer effective to adhere to surrounding skin and to keep the first layer in contact with the wound. In addition there is provided a wound dressing foil that comprises collagen and a plastic compound that can provide a foil shape. Furthermore, methods of dressing wounds utilizing the wound dressings and wound dressing foil are provided herein.Type: GrantFiled: March 13, 2013Date of Patent: March 3, 2020Assignee: MAM Holdings of West Florida, L.L.C.Inventor: Carl Randall Harrell
-
Patent number: 10519420Abstract: Provided herein is a pre-Caesarean method for collecting amniotic fluid from a patient. A needle is inserted into the incision site for the future C-section, which may be under ultrasound guidance, through which the amniotic fluid is drawn under a low level suction and, optionally, gravity to a sterile collection container. The method encompasses filtering and/or irradiating the amniotic fluid to collect biomolecules of interest such as growth factors and/or stem cells. Also provided is the sterile amniotic fluid or filtrates thereof collected by the method described herein.Type: GrantFiled: January 22, 2018Date of Patent: December 31, 2019Assignee: MAM Holdings of West Florida, L.L.C.Inventor: Carl Randall Harrell
-
Patent number: 10485521Abstract: Provided herein is a method for sterilely filtering amniotic fluid from selected caesarean sections of an individual. The amniotic fluid is first centrifuged at 5,000 to 10,000 rpm for 30 to 60 minutes and filtered through filters with about 5 to about 10 ?m pore size. Next, the fluid is sequentially filtered through a series of membrane filters with the pore sizes 1 ?m and 0.45 or/and 0.2 ?m. The filtrate is then aseptically transferred to and sealed in syringes or vials. The fluid is subsequently lyophilized to obtain the lyophilisate of amniotic fluid. Amniotic fluid is reconstituted by adding sterile water to the lyophilisate, and the reconstituted fluid is used for wound healing, cosmetic, orthopedic or ophthalmic applications, particularly for the treatment of dry eyes.Type: GrantFiled: October 7, 2014Date of Patent: November 26, 2019Assignee: MAM Holdings of West Florida, L.L.C.Inventor: Carl Randall Harrell
-
Patent number: 9907821Abstract: A human amniotic fluid formulation has been developed for administration into a joint or associated soft tissue such as a tendon or ligament for treatment of pain, degeneration or injury. The formulation is a sterile de-cellularized human amniotic fluid (D-HAF), devoid of amniotic stemcells and elements of micronized membrane or chorion particles, which has not been heat treated or treated with ethidium bromide. The formulation is optionally diluted, or concentrated, depending on the severity of the disorder or injury. Examples demonstrate efficacy in treatment of pain, disease, disorder, degeneration or injury of a joint or associated soft.Type: GrantFiled: October 10, 2016Date of Patent: March 6, 2018Assignee: MAM Holdings of West Florida, L.L.C.Inventor: Carl Randall Harrell
-
Patent number: 9884078Abstract: Methods of preparing sterile de-cellularized human amniotic fluid that is amenable for long-term storage without loss of biological functions have been developed. In particular, the methods involve refrigeration steps to maximize shelf-life while retaining most of the important growth factors and other molecules present in the fresh amniotic fluid for effective therapeutic application. Use of the compositions is intended for therapeutic purposes and will alleviate pain or discomfort associated with any disorders or diseases, particularly those involving eyes and joints, or fibrotic disorders such as COPD.Type: GrantFiled: February 17, 2017Date of Patent: February 6, 2018Assignee: MAM HOLDINGS OF WEST FLORIDA, L.L.C.Inventor: Carl Randall Harrell
-
Patent number: 9579350Abstract: Methods of preparing sterile de-cellularized human amniotic fluid that is amenable for long-term storage without loss of biological functions have been developed. In particular, the methods involve refrigeration steps to maximize shelf-life while retaining most of the important growth factors and other molecules present in the fresh amniotic fluid for effective therapeutic application. Use of the compositions is intended for therapeutic purposes and will alleviate pain or discomfort associated with any disorders or diseases, particularly those involving eyes and joints, or fibrotic disorders such as COPD.Type: GrantFiled: February 25, 2016Date of Patent: February 28, 2017Assignee: MAM Holdings of West Florida, L.L.C.Inventor: Carl Randall Harrell